Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900021647Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of lidocaine in respiratory complication (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Perioperative respiratory adverse events. Planned start Mar 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900021647.